Perioperatively Inhaled Hydrogen Gas Diminishes Neurologic Injury Following Experimental Circulatory Arrest in Swine

Alexis R Cole, Dorothy A Perry, Ali Raza, Arthur P Nedder, Elizabeth Pollack, William L Regan, Sarah J van den Bosch, Brian D Polizzotti, Edward Yang, Daniel Davila, Onur Afacan, Simon K Warfield, Yangming Ou, Brenda Sefton, Allen D Everett, Jeffrey J Neil, Hart G W Lidov, John E Mayer, John N Kheir, Alexis R Cole, Dorothy A Perry, Ali Raza, Arthur P Nedder, Elizabeth Pollack, William L Regan, Sarah J van den Bosch, Brian D Polizzotti, Edward Yang, Daniel Davila, Onur Afacan, Simon K Warfield, Yangming Ou, Brenda Sefton, Allen D Everett, Jeffrey J Neil, Hart G W Lidov, John E Mayer, John N Kheir

Abstract

This study used a swine model of mildly hypothermic prolonged circulatory arrest and found that the addition of 2.4% inhaled hydrogen gas to inspiratory gases during and after the ischemic insult significantly decreased neurologic and renal injury compared with controls. With proper precautions, inhalational hydrogen may be administered safely through conventional ventilators and may represent a complementary therapy that can be easily incorporated into current workflows. In the future, inhaled hydrogen may diminish the sequelae of ischemia that occurs in congenital heart surgery, cardiac arrest, extracorporeal life-support events, acute myocardial infarction, stroke, and organ transplantation.

Keywords: CPB, cardiopulmonary bypass; GFAP, glial fibrillatory acidic protein; H2, hydrogen gas; PDI, Psychomotor Development Index; SNDS, Swine Neurodevelopment Score; circulatory arrest; hydrogen gas; ischemia-reperfusion injury; neuroprotection; •OH, hydroxyl radical.

Figures

Graphical abstract
Graphical abstract
Figure 1
Figure 1
Presumed Mechanism of H2 Action in the Setting of Ischemia Ischemic insults create tissue hypoxia, stimulating a complex cascade (not shown) that results in the release of superoxide (O2−•). When O2−• is present in excess (i.e., when compensatory mechanisms become saturated), it directly causes the reduction of transition metal ions, including Fe3+ and Cu2+, which in turn, generates hydroxyl radicals (•OH) by the Fenton reaction. The •OH is the strongest of the oxidant species and is the direct effector of DNA injury and lipid membrane peroxidation, which releases HNE and MDA, causing direct cellular injury and stimulating apoptosis. Unlike O2−• and H2O2, there is no known detoxification system for •OH; therefore, scavenging •OH is a critical antioxidant process. Molecular hydrogen (H2), which freely permeates the cell wall and diffuses into the cytosol and mitochondria, reduces the hydroxyl radical to water and thus mitigates •OH-mediated tissue injury. HNE = 4-hydroxyl-2-nonenal; MDA = malondialdehyde; SOD = superoxide dismutase.
Figure 2
Figure 2
Study Protocol Neonatal swine were acclimated with bottle feedings 5 time per day (blue marks) for 5 days prior to experimentation. On the day of experimentation, swine were anesthetized and instrumented for cardiopulmonary bypass. Ischemic injury included circulatory arrest for 75 min at 25°C. Swine were then rewarmed and decannulated and underwent mechanical ventilation using a standardized intensive care protocol. Swine were ventilated for a total of 24 h (including pre- and post-operative treatments) with or without 2.4% inhaled hydrogen therapy (n = 8 swine per group). Videotaped neurologic examinations (green marks) took place prior to and daily following the circulatory arrest period. Swine underwent sedated brain MRI followed by terminal cerebral perfusion for histopathologic examination on postoperative day 3. F = Friday; M = Monday; MRI = magnetic resonance imaging; R = Thursday; RN = nursing care; S = Saturday/Sunday; W = Wednesday.
Figure 3
Figure 3
Clinical Neurologic Outcomes (A) Hydrogen-treated swine exhibited significantly higher rates of neurologically intact survival, which was defined as an SNDS ≤120 at the time of death (log-rank test: p = 0.0035). The overall rates of survival were similar between groups (log-rank test: p = 0.1435). (B) Hydrogen-treated swine exhibited significantly lower SNDS at 1, 2, and 3 days post injury (2-way ANOVA: p < 0.0001). Data for day 1 represent 8 swine per group; data for days 2 and 3 represent 8 swine in the hydrogen group and 6 in the control group (2 swine allocated to the control group died from refractory seizures and could not be successfully extubated). ***p < 0.001; **p < 0.01 for daily differences according to Sidak’s multiple comparisons post test. ANOVA = analysis of variance; DHCA = deep hypothermic circulatory arrest; SNDS = Swine Neurodevelopment Score.
Figure 4
Figure 4
Radiographic Differences Between Groups Axial T2 images (A) were assessed for radiographically apparent injuries (B), which were outlined as moderate (green) or severe (red) on a voxel-per-voxel basis. These areas of injury were corroborated by review of apparent diffusion coefficient mapping (C), which were similarly outlined (D). (E) Areas of injury were rendered in 3 dimensions and overlaid onto an image of the brain to provide a visual image of the differences in the volume of cranial injury. Data were based on brain MRI of 8 swine in the hydrogen-treated group and 6 in the control group (2 swine allocated to the control group died from refractory seizures and could not survive to day 3). (F) H2-treated animals exhibited a significantly lower volume of injury than did control animals (Student t-test: p = 0.0463). The line represents median, boxes are interquartile ranges, and error bars are minimum and maximum values.
Figure 5
Figure 5
Histopathologic Differences Between Groups Regions of radiographically apparent injury (A) (arrows) correlated well with histologically apparent injury (B), shown here by fluorescence microscopy (original magnification: ×1, using a Rhodamine filter). Neuronal injury was scored between 0 (normal) and 5 (severe neuronal injury, necrosis) for each region through identification of hypereosinophilic and/or apoptotic neurons by using both light (C) and fluorescence (D) microscopy (original magnification: ×60; bars = 50 μm). Open arrows = hypereosinophilic and apoptotic neurons. (E) As a group, hydrogen-treated swine exhibited significantly lower histologic injury scores than controls (2-way repeated measures ANOVA according to Sidak's test results: p = 0.0044). Data are based on histopathology for 8 swine in the hydrogen-treated group and 6 in the control group (2 swine allocated to the control group died from refractory seizures and did not survive to day 3). Data are means; error bars are SEM.

References

    1. Algra S.O., Jansen N.J.G., van der Tweel I. Neurological injury after neonatal cardiac surgery: a randomized, controlled trial of 2 perfusion techniques. Circulation. 2014;129:224–233.
    1. Dent C.L., Spaeth J.P., Jones B.V. Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion. J Thorac Cardiovasc Surg. 2006;131:190–197.
    1. Mahle W.T., Tavani F., Zimmerman R.A. An MRI study of neurological injury before and after congenital heart surgery. Circulation. 2002;106:I109–I114.
    1. McQuillen P.S., Barkovich A.J., Hamrick S.E.G. Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke. 2007;38:736–741.
    1. Andropoulos D.B., Hunter J.V., Nelson D.P. Brain immaturity is associated with brain injury before and after neonatal cardiac surgery with high-flow bypass and cerebral oxygenation monitoring. J Thorac Cardiovasc Surg. 2010;139:543–556.
    1. Beca J., Gunn J.K., Coleman L. New white matter brain injury after infant heart surgery is associated with diagnostic group and the use of circulatory arrest. Circulation. 2013;127:971–979.
    1. Galli K.K., Zimmerman R.A., Jarvik G.P. Periventricular leukomalacia is common after neonatal cardiac surgery. J Thorac Cardiovasc Surg. 2004;127:692–704.
    1. Creighton D.E., Robertson C.M.T., Sauve R.S. Neurocognitive, functional, and health outcomes at 5 years of age for children after complex cardiac surgery at 6 weeks of age or younger. Pediatrics. 2007;120:e478–e486.
    1. Clancy R.R., McGaurn S.A., Wernovsky G. Risk of seizures in survivors of newborn heart surgery using deep hypothermic circulatory arrest. Pediatrics. 2003;111:592–601.
    1. Bellinger D.C., Jonas R.A., Rappaport L.A. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med. 1995;332:549–555.
    1. Naim M.Y., Gaynor J.W., Chen J. Subclinical seizures identified by postoperative electroencephalographic monitoring are common after neonatal cardiac surgery. J Thorac Cardiovasc Surg. 2015;150:169–180.
    1. Rappaport L.A., Wypij D., Bellinger D.C. Relation of seizures after cardiac surgery in early infancy to neurodevelopmental outcome. Boston Circulatory Arrest Study Group. Circulation. 1998;97:773–779.
    1. Morton P.D., Ishibashi N., Jonas R.A. Neurodevelopmental abnormalities and congenital heart disease: insights into altered brain maturation. Circ Res. 2017;120:960–977.
    1. Ferradal S.L., Yuki K., Vyas R. Non-invasive assessment of cerebral blood flow and oxygen metabolism in neonates during hypothermic cardiopulmonary bypass: feasibility and clinical implications. Sci Rep. 2017;7:44117.
    1. Lanier W.L. Cerebral metabolic rate and hypothermia: their relationship with ischemic neurologic injury. J Neurosurg Anesthesiol. 1995;7:216–221.
    1. Simons J., Sood E.D., Derby C.D., Pizarro C. Predictive value of near-infrared spectroscopy on neurodevelopmental outcome after surgery for congenital heart disease in infancy. J Thorac Cardiovasc Surg. 2012;143:118–125.
    1. Duplessis A., Jonas R., Wypij D. Perioperative effects of alpha-stat versus ph-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 1997;114:991–1001.
    1. Wypij D., Jonas R.A., Bellinger D.C. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg. 2008;135:355–360.
    1. Chinopoulos C., Adam-Vizi V. Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme. FEBS J. 2006;273:433–450.
    1. Sheu S.-S., Nauduri D., Anders M.W. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochimica et Biophysica Acta. 2006;1762:256–265.
    1. Ohsawa I., Ishikawa M., Takahashi K. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688–694.
    1. Nagatani K., Wada K., Takeuchi S. Effect of hydrogen gas on the survival rate of mice following global cerebral ischemia. Shock. 2012;37:645–652.
    1. Wang P., Jia L., Chen B. Hydrogen inhalation is superior to mild hypothermia in improving cardiac function and neurological outcome in an asphyxial cardiac arrest model of rats. Shock. 2016;46:312–318.
    1. Matte G.S., del Nido P.J. History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol. 2012;44:98–103.
    1. Wernovsky G., Wypij D., Jonas R.A. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92:2226–2235.
    1. Magruder J.T., Hibino N., Collica S. Association of nadir oxygen delivery on cardiopulmonary bypass with serum glial fibrillary acidic protein levels in pediatric heart surgery patients. Interact Cardiovasc Thorac Surg. 2016;23:531–537.
    1. Forbess J.M., Ibla J.C., Lidov H.G. University of Wisconsin cerebroplegia in a piglet survival model of circulatory arrest. Ann Thor Surg. 1995;60:S494–S500.
    1. Castellanos M.R., Nehru V.M., Pirog E.C., Optiz L. Fluorescence microscopy of H&E stained cervical biopsies to assist the diagnosis and grading of CIN. Pathol Res Pract. 2018;214:605–611.
    1. Yoshida A., Asanuma H., Sasaki H. H2 Mediates cardioprotection via involvements of katp channels and permeability transition pores of mitochondria in dogs. Cardiovasc Drugs Ther. 2012;26:217–226.
    1. Fukuda K.-I., Asoh S., Ishikawa M., Yamamoto Y., Ohsawa I., Ohta S. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem. Biophys Res Commun. 2007;361:670–674.
    1. Kawamura T., Huang C.-S., Tochigi N. Inhaled hydrogen gas therapy for prevention of lung transplant-induced ischemia/reperfusion injury in rats. Transplantation. 2010;90:1344–1351.
    1. Nakao A., Kaczorowski D.J., Wang Y. Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant. 2010;29:544–553.
    1. Buchholz B.M., Kaczorowski D.J., Sugimoto R. Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant. 2008;8:2015–2024.
    1. Yu Y., Yang Y., Bian Y. Hydrogen gas protects against intestinal injury in wild type but not NRF2 knockout mice with severe sepsis by regulating HO-1 and HMGB1 release. Shock. 2017;48:364–370.
    1. Huo T.-T., Zeng Y., Liu X.-N. Hydrogen-rich saline improves survival and neurological outcome after cardiac arrest and cardiopulmonary resuscitation in rats. Anesth Analg. 2014;119:368–380.
    1. Ostojic S.M., Vukomanovic B., Calleja-Gonzalez J., Hoffman J.R. Effectiveness of oral and topical hydrogen for sports-related soft tissue injuries. Postgrad Med. 2014;126:187–195.
    1. Liu C., Kurokawa R., Fujino M., Hirano S., Sato B., Li X.-K. Estimation of the hydrogen concentration in rat tissue using an airtight tube following the administration of hydrogen via various routes. Sci Rep. 2014;4:5485.
    1. Tamura T., Hayashida K., Sano M. Feasibility and safety of hydrogen gas inhalation for post-cardiac arrest syndrome–first-in-human pilot study. Circ J. 2016;80:1870–1873.
    1. Katsumata Y., Sano F., Abe T. The effects of hydrogen gas inhalation on adverse left ventricular remodeling after percutaneous coronary intervention for ST-elevated myocardial infarction—first pilot study in humans. Circ J. 2017;81:940–947.
    1. Ono H., Nishijima Y., Ohta S. Hydrogen gas inhalation treatment in acute cerebral infarction: a randomized controlled clinical study on safety and neuroprotection. J Stroke Cerebrovasc Dis. 2017;26:2587–2594.
    1. Ono H., Nishijima Y., Adachi N. A basic study on molecular hydrogen (H2) inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H2 level. Medical Gas Research. 2012;2:1.

Source: PubMed

3
Sottoscrivi